Medtronic
MDT
2,077 hedge funds and large institutions have $95.7B invested in Medtronic in 2024 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 931 increasing their positions, 733 reducing their positions, and 145 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 931 | Existing positions reduced: 733
18% more capital inflows, than outflows
Capital inflows: $4.19B | Capital outflows: $3.56B
0.73% more ownership
Funds ownership: 82.01% → 82.74% (+0.73%)
0% more funds holding
Funds holding: 2,076 → 2,077 (+1)
4% less first-time investments, than exits
New positions opened: 139 | Existing positions closed: 145
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
17% less call options, than puts
Call options by funds: $643M | Put options by funds: $778M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$533M |
| 2 |
Morgan Stanley
New York
|
+$318M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$271M |
| 4 |
National Pension Service
Jeonju-Si, Jeollabuk-Do,
South Korea
|
+$194M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$440M |
| 2 |
BlackRock
New York
|
-$392M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$290M |
| 4 |
Millennium Management
New York
|
-$279M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$189M |
MDT Hedge Fund Activity: Q1 2024 in Review
2,077 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2024, worth a combined $95.7B — up 6.5% from $89.8B a quarter earlier.
Sellers outnumbered buyers: 145 funds closed out of MDT and 139 opened new positions — a net loss of 6 holders — while 733 trimmed existing stakes and 931 added.
The largest buyer was JP Morgan Chase, adding an estimated $533M. The largest seller was Wells Fargo, cutting an estimated $440M.
- 2,077 institutional investors held Medtronic (MDT) as of Q1 2024, up from 2,076 in Q4 2023.
- Funds reported $95.7B of Medtronic stock for Q1 2024, up 6.5% quarter-over-quarter.
- 139 funds opened new Medtronic positions in Q1 2024 and 145 closed out, a net change of -6 holders.
- The largest Medtronic buyer in Q1 2024 was JP Morgan Chase, an estimated $533M added.
- The largest Medtronic seller in Q1 2024 was Wells Fargo, an estimated $440M sold.
Based on aggregated 13F filings for Q1 2024.